Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 -35.69M
December 31, 2024 -93.42M
December 31, 2023 -41.56M
December 31, 2022 -28.59M
December 31, 2021 -34.04M
Date Value
December 31, 2020 -54.14M
December 31, 2019 -48.28M
December 31, 2018 -31.83M
December 31, 2017 -24.29M
December 31, 2016 -13.95M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Harmony Biosciences Holdings, Inc. 348.20M
Johnson & Johnson 24.53B
United Therapeutics Corp. 1.561B
Amneal Pharmaceuticals, Inc. 339.99M
Pfizer Inc. 11.70B